265 related articles for article (PubMed ID: 25612903)
21. Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
Cheng CT; Castro G; Liu CH; Lau P
Clin Chim Acta; 2019 May; 492():12-19. PubMed ID: 30711524
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
[TBL] [Abstract][Full Text] [Related]
23. Effective tumor targeting: strategies for the delivery of Armed Antibodies.
MacDonald GC; Glover N
Curr Opin Drug Discov Devel; 2005 Mar; 8(2):177-83. PubMed ID: 15782542
[TBL] [Abstract][Full Text] [Related]
24. Complex adaptive therapeutic strategy (CATS) for cancer.
Cho YW; Kim SY; Kwon IC; Kim IS
J Control Release; 2014 Feb; 175():43-7. PubMed ID: 24362042
[TBL] [Abstract][Full Text] [Related]
25. Targeted Nanoparticle Drug Delivery System for the Enhancement of Cancer Immunotherapy.
Zhang H; Wu Y; Hu Y; Li X; Zhao M; Lv Z
J Biomed Nanotechnol; 2019 Sep; 15(9):1839-1866. PubMed ID: 31387674
[TBL] [Abstract][Full Text] [Related]
26. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
27. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
[TBL] [Abstract][Full Text] [Related]
28. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology in the arena of cancer immunotherapy.
Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
[TBL] [Abstract][Full Text] [Related]
30. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
[TBL] [Abstract][Full Text] [Related]
31. Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.
Torres Andón F; Alonso MJ
J Drug Target; 2015; 23(7-8):656-71. PubMed ID: 26453162
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.
Mukalel AJ; Riley RS; Zhang R; Mitchell MJ
Cancer Lett; 2019 Aug; 458():102-112. PubMed ID: 31100411
[TBL] [Abstract][Full Text] [Related]
33. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-based immunotherapy for cancer.
Shao K; Singha S; Clemente-Casares X; Tsai S; Yang Y; Santamaria P
ACS Nano; 2015 Jan; 9(1):16-30. PubMed ID: 25469470
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles and targeted drug delivery in cancer therapy.
Bahrami B; Hojjat-Farsangi M; Mohammadi H; Anvari E; Ghalamfarsa G; Yousefi M; Jadidi-Niaragh F
Immunol Lett; 2017 Oct; 190():64-83. PubMed ID: 28760499
[TBL] [Abstract][Full Text] [Related]
36. Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting.
Ahmad A; Khan F; Mishra RK; Khan R
J Med Chem; 2019 Dec; 62(23):10475-10496. PubMed ID: 31339714
[TBL] [Abstract][Full Text] [Related]
37. Integration of nano drug-delivery system with cancer immunotherapy.
Nakamura T; Harashima H
Ther Deliv; 2017 Nov; 8(11):987-1000. PubMed ID: 29061103
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
Klippstein R; Pozo D
Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
[TBL] [Abstract][Full Text] [Related]
39. Cancer therapy and vaccination.
Aly HA
J Immunol Methods; 2012 Aug; 382(1-2):1-23. PubMed ID: 22658969
[TBL] [Abstract][Full Text] [Related]
40. [Progress of mesoporous silica nanoparticles in targeting drug delivery system of antitumor drug].
Zhang HM; Mo S; Liu XQ; Han FM; Wang JY; Wang ZM
Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3450-5. PubMed ID: 26978988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
